Clinical Trial Update: A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures [Phase 2]

View source ↗

Summary

A Phase 2 long-term study of RAP-219 for safety and effectiveness in adults with focal onset seizures is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Focal Epilepsy

Drugs mentioned

• RAP-219

Snippet

Sponsor: Rapport Therapeutics Inc. | Conditions: Focal Epilepsy, Epilepsy | Phase 2 | Status: RECRUITING